Top leads for swine influenza A/H1N1 virus revealed by steered molecular dynamics approach

Journal of Chemical Information and Modeling

Volumn 50, Issue 12, 2010, Pages 2236-2247

  Mai, Binh Khanh ^a   Viet, Man Hoang ^b   Li, Mai Suan ^b  

^a INSTITUTE FOR COMPUTATIONAL SCIENCE AND TECHNOLOGY   (Viet Nam)

^b INSTITUTE OF PHYSICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL AGENTS; DRUG THERAPY; GLYCOPROTEINS; LIGANDS; MOLECULAR DYNAMICS; VAN DER WAALS FORCES; VIRUSES;

BINDING ABILITIES; BINDING AFFINITIES; BINDING FREE ENERGY; DRUG-RESISTANT STRAINS; GROMOS FORCE FIELDS; POISSON BOLTZMANN SURFACE AREAS (PBSA); STEERED MOLECULAR DYNAMICS; THERAPEUTIC APPLICATION;

BINDING ENERGY;

ANTIVIRUS AGENT; LIGAND; SIALIDASE;

ANIMAL; ARTICLE; CHEMISTRY; CONFORMATION; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; INFLUENZA VIRUS A H1N1; MECHANICS; METABOLISM; METHODOLOGY; MOLECULAR DYNAMICS; REPRODUCIBILITY; SWINE; THERMODYNAMICS;

ANIMALS; ANTIVIRAL AGENTS; DRUG EVALUATION, PRECLINICAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; LIGANDS; MECHANICAL PROCESSES; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; NEURAMINIDASE; REPRODUCIBILITY OF RESULTS; SWINE; THERMODYNAMICS;

EID: 78650686774     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci100346s     Document Type: Article

References (91)

1. WHO A revision of the system of nomenclature for influenza viruses: A WHO memorandum Bull. W. H. O. 1980, 58, 585-591
2. Murphy, B. R.; Webster, R. G. In Fields Virology, 3 rd ed.; Lippincott-Raven: Philadelphia, 1996.
3. Kobasa, D.; Kodihalli, S.; Luo, M.; Castrucci, M. R.; Donatelli, I.; Suzuki, Y.; Suzuki, T.; Kawaoka, Y. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase J. Virol. 1999, 73, 6743-6751
4. Taisuke, H.; Kawaoka, Y. Pandemic threat posed by avian influenza A viruses Clin. Microbiol. Rev. Soc. 2001, 14, 129-149
5. WHO. Pandemic (H1N1) 2009, briefing note 4, http://www.who.int/csr/ disease/swineflu/notes/h1n1ituation0090724/en/index.html (accessed July 24, 2009).
6. Ferguson, N. M.; Fraser, C.; Donnelly, C. A.; Ghani, A. C.; Anderson, R. M. Public health risk from the avian H5N1 influenza epidemic Science 2004, 304, 968-969
7. Le, Q. M. Avian flu: Isolation of drug-resistant H5N1 virus Nature 2005, 437, 1108
8. Webster, R. G.; Govorkova, E. A. H5N1 influenza-continuing evolution and spread N. Engl. J. Med. 2006, 355, 2174-2177
9. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina; Center for Disease Control and Prevention (CDC): United States, 2009; http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm5835a1.htm (accessed September 11, 2009).
10. Oseltamivir-resistant novel influenza A(H1N1) virus infection in two immunosup-pressed patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 58: 893-896.
11. Wkly Epidemiol Rec, Pandemic (H1N1) 2009, briefing note 1 Virus resistant to oseltamivir (tamiflu) identified, http://www.who.int/csr/disease/swineflu/ notes/h1n1ntiviralesistance0090708/en/index.html, (accessed July 8, 2009).
12. Cheng, L. S.; Amaro, R. E.; Xu, D.; Li, W. W.; Arzberger, P. W.; McCammon, J. A. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase J. Med. Chem. 2008, 51, 3878-3894
13. Sanner, M. F. A. A component-based software environment for visualizing large macromolecular assemblies Structure 2005, 13, 447-462
14. Nguyen, H. T.; Le, L.; Truong, T. N. Top-hits for A/H1N1 identified by virtual screening using ensemble-based docking. PLoS Curr. 2009, 10.1371/currents.RRN1030.
15. Li, Y.; Zhou, B.; Wang, R. Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1 J. Mol. Graphics Modell. 2009, 28, 203-219
16. Mihajlovic, M. L.; Mitrasinovic, P. M. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV) Biophys. Chem. 2008, 136, 152-158
17. Garcia-Sosa, A. T.; Sild, S.; Maran, U. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza h6n1 wild-type neuraminidase and of the oseltamivir-resistant h274y variant J. Chem. Inf. Model. 2008, 48, 2074-2080
18. Du, Q. S.; Wang, S. Q.; Chou, K. C. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus Biochem. Biophys. Res. Commun. 2007, 362, 525-531
19. Mihajlovic, M. L.; Mitrasinovic, P. M. Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs) Mol. Simul. 2009, 35, 311-324
20. Mihajlovic, M. L.; Mitrasinovic, P. M. Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study J. Serb. Chem. Soc. 2009, 74, 1-13
21. Mitrasinovic, P. M. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA) Biophys. Chem. 2009, 140, 35-38
22. Mitrasinovic, P. M. Advances in the structure-based design of the influenza A neuraminidase inhibitors Curr. Drug Targets 2010, 11, 315-326
23. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 1998, 19, 1639-1662
24. Garcia-Sosa, A. T.; Sild, S.; Maran, U. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant J. Chem. Inf. Model. 2008, 48, 2074-2080
25. Collins, P. J.; Haire, L. F.; YP, Y. P. L.; Liu, J. F.; Russell, R. J.; Walker, P. A.; Skehel, J. J.; Martin, S. R.; Hay, A. J.; Gamblin, S. J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants Nature 2008, 453, 1258-1261
26. Wall, I. D.; Leach, A. R.; Salt, D. W.; Ford, M. G.; Essex, J. W. Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method J. Med. Chem. 1999, 42, 5142-5152
27. Rungrotmongkol, T.; Udommaneethanakit, T.; Malaisree, M.; Nunthaboot, N.; Intharathep, P.; Sompornpisut, P.; Hannongbua, S. How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants Biophys. Chem. 2009, 145, 29-36
28. Park, J. W.; Jo, W. H. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus Eur. J. Med. Chem. 2009, 45, 536-541
29. Zwanzig, R. W. High-temperature equation of state by a perturbation method. I. Nonpolar gases J. Chem. Phys. 1954, 22, 1420-1426
30. Bren, U.; Martinek, V.; Florian, J. Free energy simulations of uncatalyzed DNA replication fidelity: Structure and stability of T center dot G and dTTP center dot G terminal DNA mismatches flanked by a single dangling nucleotide J. Phys. Chem. B 2006, 110, 10557-10566
31. Lee, F. S.; Chu, Z. T.; Bolger, M. B.; Warshel, A. Calculation of antibody antigen interactions-microscopic and semimicroscopic evaluation of the free energies of binding of phosphorylcholine analogs to MCPC603 Protein Eng. 1992, 5, 215-228
32. Bren, U.; Lah, J.; Bren, M.; Martinek, V.; Florian, J. DNA duplex stability: the role of preorganized electrostatics J. Phys. Chem. B 2010, 114, 2876-2885
33. Wang, N. X.; Zheng, J. J. Computational studies of H5N1 influenza virus resistance to oseltamivir Protein Sci. 2009, 18, 707-715
34. Masukawa, K. M.; Kollman, P. A.; Kuntz, I. D. Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations J. Med. Chem. 2003, 46, 5628-5637
35. Bonnet, P.; Bryce, R. A. Molecular dynamics and free energy analysis of neuraminidase ligand interactions Protein Sci. 2004, 13, 946-957
36. Chachra, R.; Rizzo, R. C. Origins of resistance conferred by the r292k neuraminidase mutation via molecular dynamics and free energy calculations J. Chem. Theory Comput. 2008, 4, 1526-1540
37. Lawrenz, M.; Baron, R.; McCammon., J. A. Independent-trajectories thermodynamic-integration free-energy changes for biomolecular systems: Determinants of H5N1 avian influenza virus neuraminidase inhibition by peramivir J. Chem. Theory Comput. 2008, 5, 1106-1116
38. Isralewitz, B.; Baudry, J.; Gullingsrud, J.; Kosztin, D.; Schulten, K. Steered molecular dynamics investigations of protein function J. Mol. Graphics Modell. 2001, 19, 13-25 (Pubitemid 32411500)
39. Isralewitz, B.; Gao, M.; Schulten, K. Steered molecular dynamics and mechanical functions of proteins Curr. Opin. Struct. Biol. 2001, 11, 224-230 (Pubitemid 32289426)
40. Lu, H.; Isralewitz, B.; Krammer, A.; Vogel, V.; Schulten, K. Unfolding of titin immunoglobulin domains by steered molecular dynamics simulation Biophys. J. 1998, 75, 662-671
41. Isralewitz, B.; Izrailev, S.; Schulten, K. Binding pathway of retinal to bacterioopsin: A prediction by molecular dynamics simulations Biophys. J. 1997, 73, 2972-2979
42. Grubmuller, H.; Heymann, B.; Tavan, P. Ligand binding: molecular mechanics calculation of the streptavidin-biotin rupture force Science 1996, 271, 997-999
43. Garter, F.; de Groot, B. L.; Jiang, H.; Grubmuller., H. Ligand-release pathways in the pheromone-binding protein of Bombyx mori Structure. 2006, 14, 1567-1576
44. Xu, Y.; Shen, J.; Luo, X.; Silman, I.; Sussman, J. L.; Chen, K.; Jiang, H. How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations J. Am. Chem. Soc. 2003, 125, 11340-11349
45. Shen, L.; Shen, J.; Luo, X.; Cheng, F.; Xu, Y.; Chen, K.; Edward, A.; Ding, J.; Jiang, H. Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT Biophys. J. 2003, 84, 3547-3563
46. Park, S.; Khalili-Araghi, F.; Tajkhorshid, E.; Schulten, K. Free energy calculation from steered molecular dynamics simulations using Jarzynski's equality J. Chem. Phys. 2003, 119, 3559-3566
47. Jensen, M. O.; Park, S.; Tajkhorshid, E.; Schulten, K. Energetics of glycerol conduction through aquaglyceroporin GlpF Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 6731-6736
48. Zhang, D.; Gullingsrud, J.; McCammon, J. A. Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain J. Am. Chem. Soc. 2006, 128, 3019-3026
49. Ytreberg, F. M. Absolute FKBP binding affinities obtained via nonequilibrium unbinding simulations J. Chem. Phys. 2009, 130, 164906
50. Hajjar, E.; Perahia, D.; Debat, H.; Nespoulous, C.; Robert, C. H. Odorant binding and conformational dynamics in the odorant-binding protein J. Biol. Chem. 2006, 281, 29929-29937
51. Wang, J.; Cieplak, P.; Kollman, P. A. How well does restrained electrostatic potential (RESP) model perform organic and biological molecules J. Comput. Chem. 2000, 21, 1049-1074
52. Srinivasan, J.; Cheatham, T. E., III; Cieplak, P.; Kollman, P. A.; Case, D. A. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices J. Am. Chem. Soc. 1998, 120, 9401-9409 (Pubitemid 28452628)
53. Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; Donini, O.; Cieplak, P.; Srinivasan, J.; Case, D. A.; Cheatham, T. C., III Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models Acc. Chem. Res. 2000, 33, 889-897
54. Massova, I.; Kollman, P. A. Computational alanine scanning to probe protein-protein interactions: A novel approach to evaluate binding free energies J. Am. Chem. Soc. 1999, 121, 8133-8143 (Pubitemid 29444447)
55. Ganoth, A.; Friedman, R.; Nachliel, E.; Gutman, M. A molecular dynamics study and free energy analysis of complexes between the Mlc1p protein and two IQ motif peptides Biophys. J. 2006, 91, 2436-2450
56. Taranta, M.; Bizzarri, A. R.; Cannistraro, S. Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin J. Mol. Recognit. 2008, 22, 215-222
57. Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation J. Chem. Theory Comput. 2008, 4, 435-447
58. Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin, Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel, J. J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design Nature 2006, 443, 45-49
59. Rungrotmongkol, T.; Intharathep, P.; Malaisree, M.; Nunthaboot, N.; Kaiyawet, N.; Sompornpisut, P.; Payungporn, S.; Poovorawan, Y.; Hannongbua, S. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus Biochem. Biophys. Res. Commun. 2009, 385, 390-394
60. van Gunsteren, W.; Billeter, S. R.; Eising, A. A.; Hunenberger, P. H.; Kruger, P.; Mark, A. E.; Scott, W. R. P.; Tironi., I. G. Biomolecular Simulation: The GROMOS96 Manual and User Guide; Vdf Hochschulverlag AG an der ETH Zurich: Zurich, Switzerland, 1996.
61. van Aalten, D. M. F.; Bywater, R.; Findlay, J. B. C.; Hendlich, M.; Hooft, R. W. W.; Vriend, G. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules J. Comput.-Aided. Mol. Des. 1996, 10, 255-262
62. Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; Hermans, J. Intermolecular Forces; Reidel, Dordrecht, The Netherlands, 1981.
63. Hockney, R. W.; Goel, S. P.; Eastwood, J. Quit high resolution computer models of plasma J. Comput. Phys. 1974, 14, 148-158
64. Hess, B.; Bekker, H.; Berendsen, H. J. C.; Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations J. Comput. Chem. 1997, 18, 1463-1472
65. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N log(N) method for Ewald sums in large systems J. Chem. Phys. 1993, 98, 10089-10092
66. Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; Dinola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath J. Chem. Phys. 1984, 81, 3684-3690
67. Parrinello, M.; Rahman, A. Polymorphic transitions in single crystals: A new molecular dynamics method J. Appl. Phys. 1981, 52, 7182-7190
68. Kumar, S.; Li, M. S. Biomolecules under mechanical force Phys. Rep. 2010, 486, 1-74
69. Kouza, M.; Hu, C. K.; Li, M. S. New force replica exchange method and protein folding pathways probed by force-clamp technique J. Chem. Phys. 2008, 128 045103
70. Carrion-Vazquez, M.; Li, H. B.; Lu, H.; Marszalek, P. E.; Oberhauser, A. F.; Fernandez, J. M. The mechanical stability of ubiquitin is linkage dependent Nat. Struct. Biol. 2003, 10, 738-743
71. Petrek, M.; Otyepka, M.; Banas, P.; Kosinova, P.; Koca1, J.; Damborsky, J. CAVER: A new tool to explore routes from protein clefts, pockets and cavities BMC Bioinf. 2006, 7, 316
72. Bren, U.; Martinek, V.; Florian, J. Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method J. Phys. Chem. B 2006, 110, 12782-12788
73. Bren, M.; Florian, J.; Mavri, J.; Bren, U. Do all pieces make a whole? Thiele cumulants and the free energy decomposition Theor. Chem. Acc. 2007, 117, 535-540
74. Sharp, K. A.; Honig, B. Electrostatic interactions in macromolecules: Theory and applications Annu. Rev. Biophys. Biophys. Chem. 1990, 19, 301-332
75. Baker, N. A.; Sept, D.; Joseph, S.; Holst, M. J.; McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10037-10041
76. Sitkoff, D.; Sharp, K. A.; Honig, B. Accurate calculation of hydration free energies using macroscopic solvent models J. Phys. Chem. 1994, 97, 1978-1988
77. Shrake, A.; Rupley, J. A. Environment and exposure to solvent of protein atoms-lysozyme and insulin J. Mol. Biol. 1973, 79, 351-371
78. Shanno, D. F. Conditioning of quasi-Newton methods for function minimization Math. Comput. 1970, 24, 647-656
79. McQuarrie, D. A. Statistical Thermodynamics, 2 nd ed.; Harper and Row: New York, 1973.
80. de Jong, M. D.; Thanh, T. T.; Khanh, T. H.; Hien, V. M.; Smith, G. J. D.; Chau, N. V.; Cam, B. V.; Qui, P. T.; Ha, D. Q.; Guan, Y.; Peris, J. M. S.; Hien, T. T.; Farrar, J. Oseltamivir resistance during treatment of influenza A (H5N1) infection N. Engl. J. Med. 2005, 353, 2667-2672
81. Bright, R. A.; Medina, M. J.; Xu, X. Y.; Perez-Oronoz, G.; Wallis, T. R.; Davis, X. H. M.; Povinelli, L.; Cox, N. J.; Klimov, A. I. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern Lancet 2005, 366, 1175-1181
82. Udommaneethanakit, T.; Rungrotmongkol, T.; U, U. B.; Frecer, V.; Miertus, S. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues J. Chem. Inf. Model. 2009, 49, 2323-2332
83. Cornell, W. D.; Ceplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A 2nd generation force-filed for the simulation of proteins, nucleic-acids, and organic molecules J. Am. Chem. Soc. 1995, 117, 5179-5197
84. Govorkova, E. A.; Leneva, I. A.; Goloubeva, O. G.; Bush, K.; Webster, R. G. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses Antimicrob. Agents Chemother. 2001, 45, 2723-2732
85. Roberts, N. A.; Govorkova, E. A. The activity of neuraminidase inhibitor oseltamivir against all subtypes of influenza viruses. In Global View of the Fight against Influenza; Mitrasinovic, P. M., Ed; Nova Science Publishers Inc: New York, 2009; pp 93 - 118.
86. Liu, X.; Wang, X.; Jiang, H. A steered molecular dynamics method with direction optimization and its applications on ligand molecule dissociation J. Biochem. Biophys. Methods 2008, 70, 857-864
87. Yang, K.; Liu, X.; Wang, X.; Jiang, H. A steered molecular dynamics method with adaptive direction adjustments Biochem. Biophys. Res. Commun. 2009, 379, 494-498
88. Lu, H.; Schulten, K. The key event in force-induced unfolding of titin's immunoglobulin domain Biophys. J. 2000, 79, 51-65
89. Colizzi, F.; Perozzo, R.; Scapozza, L.; Recanatini, M.; Cavalli, A. Single-molecule pulling simulations can discern active from inactive enzyme inhibitors J. Am. Chem. Soc. 2010, 132, 7361-7371
90. Jorgensen, W. L. Drug discovery pulled from a proteins's embrace Nature 2010, 466, 42-43
91. Humphrey, W.; Dalke, A.; Schulten, K. VMD-Visual molecular dynamics J. Mol. Graphics 1996, 14, 33-38